Bevacizumab for refractory adverse radiation effects after stereotactic radiosurgery

Journal of Neuro-Oncology

Volumn 115, Issue 2, 2013, Pages 217-223

  Deibert, Christopher P ^a   Ahluwalia, Manmeet S ^b   Sheehan, Jason P ^c   Link, Michael J ^d   Hasegawa, Toshinori ^e   Yomo, Shoji ^f   Feng, Wu Han ^g   Li, Pan ^h   Flickinger, John C ^a   Lunsford, L Dade ^a   Kondziolka, Douglas ^a,i  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d MAYO CLINIC   (United States)

^e KOMAKI CITY HOSPITAL   (Japan)

^f San ai Hospital   (Japan)

^g Department of Radiotherapy   (China)

^h FUDAN UNIVERSITY   (China)

ⁱ NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bevacizumab; Complication; Edema; Inflammation; Radiation injury; Radiosurgery

Indexed keywords

BEVACIZUMAB; CONTRAST MEDIUM; CORTICOSTEROID;

ADVERSE OUTCOME; ARTERIOVENOUS MALFORMATION; ARTICLE; ATAXIA; BRAIN TUMOR; BREAST CANCER; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; COLORECTAL CANCER; CONFUSION; CONGENITAL BLOOD VESSEL MALFORMATION; CONTRAST ENHANCEMENT; CORTICOSTEROID THERAPY; DOSE RESPONSE; EDEMA; GAMMA KNIFE; HEADACHE; HEMANGIOPERICYTOMA; HUMAN; IMAGE QUALITY; LUNG NON SMALL CELL CANCER; MELANOMA; MENINGIOMA; METASTASIS; NAUSEA AND VOMITING; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION DOSE; RADIATION INJURY; RECURRENT DISEASE; RETROSPECTIVE STUDY; SENSORY DYSFUNCTION; SPEECH DISORDER; STEREOTACTIC RADIOSURGERY; TREATMENT DURATION; TREATMENT RESPONSE; UTERINE TUBE CARCINOMA; VISUAL DISORDER; WEAKNESS;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; BRAIN NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RADIATION INJURIES; RADIOSURGERY; RETROSPECTIVE STUDIES;

EID: 84886589532     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-013-1214-3     Document Type: Article

References (16)

1. Giglio P, Gilbert MR (2003) Cerebral radiation necrosis. Neurology 9:180-188
2. Glantz MJ, Burger PC, Friedman AH et al (1994) Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology 44:2020-2027
3. Rahmathulla G, Recinos PF, Valerio JE, Chao S, Barnett GH (2012) Laser interstitial thermal therapy for focal cerebral radiation necrosis: a case report and literature review. Stereotact Funct Neurosurg 90:192-200
4. Kano K, Kondziolka D, Lobato-Polo J, Zorro O, Flickinger JC, Lunsford LD (2010) T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery. Neurosurgery 66:486-492
5. Williamson R, Kondziolka D, Kanaan H, Lunsford LD, Flickinger JC (2008) Adverse radiation effects after radiosurgery may benefit from oral vitamin e and pentoxifylline therapy: a pilot study. Stereotact Funct Neurosurg 86(6):359-366
6. Gonzalez J, Kumar A, Conrad C, Levin V (2008) Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys 67(2):323-326
7. Levin V, Bidaut L, Hou P, Kumar A, Wefel J, Bekele N, Prabhu S, Loghin M, Gilbert M, Jackson E (2011) Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Rad Oncol Biol Phys 79(5):1487-1495
8. Trocuator R, Zuniga R, Mohan Y, Rock J, Doyle T, Anderson J, Gutierrez J, Ryu S, Jain R, Rosenblum M, Mikkelsen T (2009) Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. J Neuroonol 94:63-68
9. Wong E, Huberman M, Lu X, Mahadevan A (2008) Bevacizumab reverses cerebral radiation necrosis. J Clin Oncol 26(34):5649-5650
10. Matuschek C, Bolke E, Nawatny J, Hoffmann T, Peiper M, Orth K, Gerber P, Rusnak E, Lammering G, Budach W (2011) Bevacizumab as a treatment option for radiation-induced cerebral necrosis. Strahlenther Onkol 187:135-139
11. Williams B, Park D, Sheehan J (2012) Bevacizumab used for the treatment of severe, refractory perilesional edema due to an arteriovenous malformation treated with stereotactic radiosurgery. J Neurosurg 116:972-977
12. Furuse M, Kawabata S, Kuroiwa T, Miyatake S (2011) Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases. J Neurooncol 102:471-475
13. Benoit A, Ducray F, Cartalat-Carel S, Psimaras D, Ricard D, Honnorat J (2011) Favorable outcome with bevacizumab after poor outcome with steroids in a patient with temporal lobe brainstem radiation necrosis. J Neurol 258:328-329
14. Sanborn RS, Danizh SF, Rosenfeld MR, O'Rougke D, Lee JY (2011) Treatment of steroid refractory, gamma knife related necrosis with bevacizumab: case report and review of the literature. Clin Neurol Neurosurg 113:798-802
15. Jeyaretna D, Curry W, Batchelor T, Stemmer-Rachamimov A, Plotkin S (2011) Exacerbation of cerebral radiation necrosis by bevacizumab. J Clin Oncol 29(7):e159-e162
16. Nonoguchi N, Miyatake S, Fukumoto M, Furuse M, Hiramatsu R, Kawabata S, Kuroiwa T, Tsuji M, Fukumoto M, Ono K (2011) The distribution of vascular endothelial growth factor-producing cells in clinical radiation necrosis of the brain: pathological consideration of their potential roles. J Neurooncol 105:423-431